GWM
EVOK

Geneos Wealth Management’s Evoke Pharma EVOK Stock Holding History

Geneos Wealth Management’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3
Closed -$1K – 2094
2017
Q1 		$1K Buy
+3
New +$1.23K ﹤0.01% 1975

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
PM
Precept Management Dallas, Texas $126M AUM 36.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geneos Wealth Management's EVOK Position: Q2 2017 in Review

Geneos Wealth Management sold out of Evoke Pharma (EVOK) in Q2 2017, closing a stake of 3 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in EVOK in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 21 funds tracked by Wall St. Rank hold EVOK as of Q2 2017.

  • Geneos Wealth Management reported no remaining Evoke Pharma position as of Q2 2017 after selling out during the quarter.
  • Geneos Wealth Management sold 3 Evoke Pharma shares in Q2 2017, an estimated $1K.
  • Geneos Wealth Management first reported a position in Evoke Pharma in Q1 2017 and held it in 1 quarter.
  • Geneos Wealth Management's Evoke Pharma position peaked at $1K in Q1 2017.
  • 21 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2017.

Based on Geneos Wealth Management's 13F filing for Q2 2017, filed 7 Sep 2021.